CYLD and diffuse large B-cell lymphoma: There was no significant difference in total CYLD or total BTK expression levels between non-GCB-DLBCL samples (non-GCB-DLBCL patients’ samples; OCI-Ly10 and HBL-1 cell lines) and control samples (lymphadenitis patients’ samples; 3T8 and RPMI1788 cell lines).